Tus kws kho mob
P53-25 Change to Interim Bill Submission Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3751 - 3760 ntawm 4179
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
commercial-general-coding-069-ambulance-services-10.24.23.pdf
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
medicaid-gc-081-inappropriate-diagnosis-code.pdf
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
medicare-gc-081-inappropriate-diagnosis-code.pdf
Tus kws kho mob
BCBS and Blue Plus Commercial Prior Authorization/Admission Notification Requirements
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
Commercial Reimbursement Policy Cellular and Gene Therapy Products
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
Medicaid Reimbursement Policy Cellular and Gene Therapy Products